StonvexLoading…
StonvexStonvexStonvexCore line items from CSBB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $14.97M | $57.04M | $41.92M | $27.21M |
Operating Income | $5.54M | $16.56M | $14.29M | $9.12M |
Net Income | $4.44M | $13.36M | $11.49M | $7.34M |
EPS (Diluted) | $1.69 | $5.07 | $4.35 | $2.78 |
Total Assets | $1.27B | $1.29B | $1.25B | $1.24B |
Total Liabilities | $1.14B | $1.17B | $1.12B | $1.12B |
Cash & Equivalents | $55.21M | $99.31M | $80.81M | $95.29M |
Free Cash Flow OCF − CapEx | $3.06M | $19.08M | $12.95M | $7.31M |
Shares Outstanding | 2.63M | 2.63M | 2.63M | 2.64M |